chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had 2 Pfizer vaccines plus 2 boosters before getting Covid; I had 2 Pfizer vaccines plus 2 boosters before getting Covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and on 04Feb2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 71 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulpha" (unspecified if ongoing), notes: Known allergies: Sulpha. Concomitant medication(s) included: SIMVASTATIN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "I had 2 Pfizer vaccines plus 2 boosters before getting Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: COVID 19 Treatment; Negative, notes: testing negative. Therapeutic measures were taken as a result of covid-19.  Clinical course: The patient got a bounce back infection after Paxlovid, 5 days after testing negative. His symptoms were a runny nose and a little fatigue. He had 2 Pfizer vaccines plus 2 boosters before getting Covid. His symptoms were a bad cough, mild temperature and fatigue for 3-4 days.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recvd vax;swelling,itching at site;devel redness,warmness in area,tenderness to touch just below inject site;small ecchymotic area at inject site;was afebrile;was told to use cold compresses & dph for couple of days;
I was very concerned that the vaccine injection was not done correctly, and not done in the right place.  Instead of doing an IM in the deltoid, the shot was a subq just above the elbow.  At first, a large red welt (10 x 8 cm.) appeared soon after.  Four days later, when I went to the clinic, it was improved.  Photos were taken.
Patient experienced lightheadedness approximately 1 minute after 2nd dose of moderna. Patient also experienced the same thing at the 1st dose. Per patient it's from needle phobia.
In late June or early July I started hearing a buzzing in both ears.  The sound has been continuous since then. I saw an ENT on October 4, 2021. A hearing test was given by an audiologist. I have a mild to moderate hearing loss and newly developed tinnitus.
Fever; Chills; Body aches; bump under skin in his armpit on right side was popped up and he described that as tennis ball cut in half, that was stuck under his arm and swollen; bump under skin in his armpit on right side was popped up and he described that as tennis ball cut in half, that was stuck under his arm and swollen; This is a spontaneous report from a contactable consumer (patient). A 53-years-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and Expiry date: not reported), via an unspecified route of administration, on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. A day after the first vaccine shot, the patient experienced fever, chills and body aches and next day he was fine. And on second day, after his vaccine, a bump under skin in his armpit on right side was popped up and he described that as tennis ball cut in half, that was stuck under his arm and swollen which was not really sore. So, the patient was very concerned right now and also he was scheduled for his second dose on 12Jul2021, so was wandering if he should get the second vaccine or not. The outcome of events fever, chills and body aches were recovered on an unknown date and for remaining events it was not recovered.  Information on the lot/batch number has been requested.
Error Scenario   Dose Administration Date   Lot Number   Recipient Date of Birth   Location Name   Patient Age at Administration Date   Adult Vaccine given to Child   1/21/2022   Health   5  Nothing happened. Child ok.
Received 2nd dose of COVID vaccine on 2/6/2021.  On 3/29/2021 developed body aches, cough, diarrhea, headache, loss of taste/smell, sore throat, and nasal congestion  Tested positive for COVID-19
Patient developed hives on her arms and hands within 15 minutes of vaccination.  Also had itchy ears and red cheeks.  Given two doses of Benedryl and symptoms improved.  She was released to home.
Feeling dizzy like I just got off a cruise ship with nausea and hot flashes on and off no fever but felt intermittently clammy/sweaty started on the 20th and resolved midday on the 21st until the morning of the 22nd, the dizzy/nausea returned and occasional sweaty/clammy feeling. Called OHS and they recommended calling pcp. PCP called in script for zofran and instructed me to take that and dramamine and call if not improved by Monday the 25th
dose was reconstituted with a different sterile diluent, not the supplied CYW-135; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA732Z, expiry date 30th August 2023) for prophylaxis.   On 11th August 2022, the patient received Menveo. On 11th August 2022, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution. On an unknown date, the outcome of the wrong solution used in drug reconstitution was unknown.   Additional Information: GSK Receipt Date: 12-AUG-2022 Reporter's Comments: The medical assistant reported that, the patient was administered a dose of Menveo, however the dose was reconstituted with a different sterile diluent, not the supplied CYW-135.  At the time of reporting, the dose had not been repeated. The reporter consented to follow up. The vaccine administration facility was the same as primary reporter. Additional Supportive Information: The patient received vaccine, which was reconstituted with a different sterile diluent, which led to wrong solution used in drug reconstitution.
At approximately 1030 RN in room to give vaccines, Hep A, Varicella and HPV #1 (administered 1042) vaccine. After administering vaccines mom reported child was not feeling well and looked pale. Upon assessment RN noted patient's drowsy, face and lips were pale. Vital signs taken at 1100, BP 88/51, T 36.4. Patient reported not feeling well, per mom his face was hot and child c/o headache. Provider notified and assessed patient. Snacks and soda given to patient and started to feel better after. Nurse noted face and lip color were back to baseline. Patient was alert and reported feeling better. RN rechecked BP at 1119, 93/56. RN notified Provider. Patient discharged home in stable condition according to staff.
2nd shot lips gums and tongue are has swollen upon day one; 2nd shot lips gums and tongue are has swollen upon day one; This is a spontaneous report from a contactable consumer or other non hcp. A 48-year-old female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 24Apr2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history was not reported and concomitant medication(s) included insulin (INSULIN). The historical vaccines include bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 04Apr2021 08:15 as DOSE 1, SINGLE for COVID-19 immunisation and experienced chills. The patient experienced drug hypersensitivity to Ibuprofen and Zpack. The patient's lips gums and tongue has swollen upon day one on 25Apr2021 08:30. Therapeutic measures were taken as a result of 2nd shot lips gums and tongue with Benadryl and steroids. The events outcome was reported as not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Seen again 10/29/03 for redness, 4" circle right arm. The follow up received on 11/18/03 states pt has not received another anthrax vaccine. Her medical exemption was renewed for 12 motnhs. She received her flu shot in November 2003 without problems. She has had no recurrence of tinnitus or otalgia. She continues to experience fatigue. Chronic fatigue-fatigue experienced after receitp of the anthrax vaccinations continues. Pt ha sexperienced daily fatigue for > 12 months. Describes as feeling tired, but not exhaused. Says she does not have adequate energy to perform usual activities, but forces self. If her baseline level of fatigue prior to immunizations was 0, she now rates her level of fatigue as a level 9 or 10 on a scale of 0-10. Occasionally, has a brief period, lasting up to 2-3 hours, where she rates level of fatigue as a level 5. Fatigue never goes away completely. Exacerbated with exertion/ exercise. Used to run daily, but can no longer run even short distances.  Forces self to work out with weights at least 3-4x/ week. Denies problems sleeping. Averages about 6 hrs of sleep/night. Denies feeling sleepy; never naps. Denies chronic muscle or joint pain, depression, sore throats, swollen lymph nodes, muscle weakness, or visual changes. Feels her memory is declining, but thinks this may be due to inattentiveness. (Focus in primarily on fatigue). Eustachian tube dysfunction-diagnosed by ENT in January 2000. Still has episodes where her ears become blocked and she is unable to fly; treats with steroid eardrops and Claritin. Onset of episodes usually related to changes in atmospheric pressure. Usually does not experience more than 1 episode/ month. Hypothyroidism-denies symptoms of hyper-or hypothyroidism; continues on replacement therapy, with last TFTs within normal limits.
vomiting that began about 8AM 3FEB93; has had no fever on other sx;
Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms; 42 Patients received bivalent booster with 38 having improvement of symptoms; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (42 Patients received bivalent booster with 38 having improvement of symptoms) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (42 Patients received bivalent booster with 38 having improvement of symptoms) and NO ADVERSE EVENT (No adverse event). At the time of the report, OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (42 Patients received bivalent booster with 38 having improvement of symptoms) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure systolic: 220. On an unknown date, Heart rate: greater than equal to 150.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms) and THERAPEUTIC RESPONSE UNEXPECTED (42 Patients received bivalent booster with 38 having improvement of symptoms).    No concomitant medication was provided by reporter.  No treatment medication was provided by reporter.  Reporter stated she has been administering the 65+ bivalent dose to her patients who have symptoms of long-haul COVID and has seen 88-90% success rate in resolving the symptoms of long-haul COVID.  It was reported that, vaccine was given to patients for long COVID between 21-Mar-2023 and 01-Aug-2023. 42 Patients received bivalent booster with 38 having improvement of symptoms and 50s or more. Patient was treated skin lesions, scary brain, body aches. No adverse reactions occurred.  This case contains information about patient 11 out of 42 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735199 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735199:Master case
COVID-19 INFECTION; SORE ARM; This spontaneous report received from a patient concerned a 60 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included seafood allergy, seasonal allergies (pollen), non-alcoholic, and non-smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk, Exp: unknown) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 15-MAR-2021, the patient experienced sore arm. On 01-APR-2021, the patient was hospitalized with Covid-19  after testing positive on 27-MAR-2021. The patient was on high level oxygen (15L @ 91% sat) and had been given remdesivir for 4 days. The patient had not been discharged from the hospital. The patient had been in a hospital for 4 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from covid-19 infection, and the outcome of sore arm was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: 20210409401-JANSSEN COVID-19 VACCINE Ad26.COV2.S- COVID-19 infection. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
whole body ache, teeth aches, sore throat, laryngitis, congestion & cough, still have cough & congestion 12 days later
received four separate Restylane Kysse Injections. Her lips plump up nicely when injected, but then deflate back to normal after two weeks. Patient reported having had the Pfizer Covid-19 vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): GL-030122-5283.  A 27-year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; hyaluronic acid (RESTYLANE) (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INTERACTION (non-serious), outcome "unknown", described as "received four separate Restylane Kysse Injections. Her lips plump up nicely when injected, but then deflate back to normal after two weeks. Patient reported having had the Pfizer Covid-19 vaccine". The action taken for hyaluronic acid was unknown.  Additional information: Patient stated, over the past year, consumer received four separate Restylane Kysse Injections. Her lips plump up nicely when injected, but then deflate back to normal after two weeks. I've had Kysse injected four times, two months apart, and the same thing happens each time. It only lasts two weeks. Then I tried Juvederm xc that lasted a while, just got it retouched up a couple of days ago. Patient reported having had the Pfizer Covid-19 vaccine, but details were not provided  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax 8APR94 & parents suspected hearing loss 6mo later;SEP95 diagnostic testing confirmed hearing loss;pt required the use of a hearing aid;
Neck is supple with left supraclavicular tender lymphadenopathy soft without fluctuance.
APROX 10-15 MIN AGTER RECIEVING FLU VACCINE FROM MY EMPLOYEE HEALTH NURSE, I STARTED WITH SEVERE ITCHING IN MY PALMS FOLLOWED BY SEVERE ITCHING ON THE SOLES OF MY FEET. I ALSO HAD RED BLOTCHY SPOTS COMING UP ON MY CHEST.
Elevated blood pressure, Tinnitus; I was prescribed medication for the blood pressure. Also, I will be seeing a ENT doctor soon. My blood pressure has improved with the medicine, but the ringing in my ear has continued.
possible STEMI, monitored  troponins and EKG's. Improved and no intervention needed, was discharged home
The evening of vax 8MAR93 pt had a sz w/temp going from 102.3 to 103.7 p /the episode; Pt eas evaluated @ ER & seen on 10MAR93 by MD;
Dry cough developed approximately 1 week after receiving vaccine #1. Two days after receiving vaccine #2 on 8/11/21, patient developed tingling in his legs and weakness.  Since the end of August 2021 he has developed worsening cough and wheezing. He was admitted on 9/10/21 for hypoxia and found to have cryptogenic organizing pneumonia.
runny nose; achy; cough; fever; tired over the weekend; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), COUGH (cough), MYALGIA (achy), FATIGUE (tired over the weekend) and PYREXIA (fever) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 038K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021 at 12:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (tired over the weekend). On 08-Feb-2021, the patient experienced COUGH (cough) and PYREXIA (fever). On 09-Feb-2021, the patient experienced RHINORRHOEA (runny nose) and MYALGIA (achy). The patient was treated with PARACETAMOL (TYLENOL) on 09-Feb-2021 for Pain and Fever, at an unspecified dose and frequency. On 07-Feb-2021, FATIGUE (tired over the weekend) had resolved. On 12-Feb-2021, COUGH (cough) and PYREXIA (fever) had resolved. At the time of the report, RHINORRHOEA (runny nose) and MYALGIA (achy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative, after first dose.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported concomitant medications as none but she usually took Vitamin D.   This case was linked to MOD-2021-068364, MOD-2021-068364.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up received: Updated patient demographics and cough event outcome to recovered/resolved. Added new event fever and lab data.
Moderna COVID-19 Vaccine  within 2 minutes of receiving the Moderna covid 19 vaccine I became hot head to toe, chest particularly hot and tight yet no sob or wheeze.  Palpitations were present, bp elevated 160/110, dizziness. after 15 -20 minutes improved however for next hour was not myself; felt a little light headed and a little difficulty getting a full breath.  Over next day, did not feel ill but not quite myself.  follow 24-48 achy, tired.
Next day of vaccine I had fatigue, muscle pain, lost of appetite, & sore arm. On the 1/28/2021 I started coughing & continued with shortness of breath since dose 1 & I still have coughing its improving but its still there.
Pt stated that the day after she received the vaccine, she broke out in hives all over her body. She stated that she had not taken any other medications other than the ones she took every morn. Pt was receiving BENADRYL and symptoms resolved by 8/28/13.
Noticed a few days after both the 2nd Moderna Vaccine in March 2021  AND the Booster Moderna Ocotber 2021 that I had all the symptoms of worse hypothyroidism. and it was hard to do gardening or my usual daily activities.  This lasted about 3 months after 2nd covid shot and is now lasting almost 3 months since I had the Booster.  My immune system should go back to normal and my Levethroid should work better. soon
Pain never goes away; Nerve damage; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a 83-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (in last 5 year the patient had Shingles 3 time in the same place that was left shoulder and neck). Previously administered products included shingles vaccine with an associated reaction of herpes zoster (received after the second bought of and shortly after that the patient got another bought of shingles, same shoulder). Concurrent medical conditions included post zoster pain and nerve injury.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain and nerve damage. On an unknown date, the outcome of the pain and nerve damage were not recovered/not resolved.   It was unknown if the reporter considered the pain and nerve damage to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. About a year later after 1st dose, the patient received the new Shingles vaccine.  No new boughts of shingles but the nerve damage was still there.  The pain had never gone away it was like having permanent case of shingles.
Information has been received from a physician concerning a 15 year old female who on unspecified dates was vaccinated with the first and second dose GARDASIL. On 20-MAY-2008, the patient received the third dose of GARDASIL. Following the immunizations the patient complained of feeling light-headed and dizzy; she didn't actually pass out, but looked like she would pass out. They laid her back on the table and it resolved without any serious sequelae. Additional information has been requested.
My partner and I received the Pfizer booster vaccine on the same time and date. Within a few days of receiving the coronavirus vaccine we both had severe symptoms of tinnitus. As of this date 11/01/2021 the symptoms are still present.
The vaccine triggered a major migraine episode- up to level 9 pain, total duration approximately 72 hours.
Received ADACEL and H1N1 vaccine 4/5/10, that evening started feeling muscle soreness (severe)- back pain and weakness. Tuesday woke up with the same symptoms - Wednesday started feeling better.
Patient returned to pharmacy and stated he received 3 doses of Shingrix. Confirmed patient was vaccinated on 8/8/2018, 12/27/2018, 9/10/2019.
When I woke up on the morning of 12/26/2021, I felt ill. I had coughing, sneezing, fatigue, loss of appetite, and weakness. On 12/30/2021, I underwent a rapid test for COVID-19 at the Clinic and got a positive result. As I had gotten my Pfizer booster just a month prior, this was a breakthrough case.